Vince & Associates Clinical Research has opened its newly expanded, 90-bed Clinical Pharmacology Research Unit. The facility features a USP 797-compliant Biosafety cabinet and full-time pharmacy staff, extensive lab areas for the processing of biomarkers and blood samples, as well as strategic alliances for specialized testing.
According to the company, the facility design delivers a “boutique hotel experience for study volunteers and a first-class scientific research setting for the biopharmaceutical industry.” Features include touch-screen entertainment systems, in-house theater room, and individually themed luxury suites.
“The unit is purpose-built for the complex trials our clients require to make earlier drug development decisions and advance their drugs to market more aggressively than ever before. For example, we provide the full technical Resources and medical expertise required for Phase I/IIa Proof of Concept (POC) studies which incorporate a single ascending dose (SAD), multiple ascending dose (MAD) and a patient proof of concept study into a single protocol,” said Dr. Brad Vince, the company’s president and medical director.